Recombinant Human GSTA4 Protein，His

Glutathione S-transferase A4 (GSTA4) is an important enzyme involved in the detoxification of reactive electrophiles, playing a crucial role in the cellular defense mechanism against oxidative stress and xenobiotic compounds. This enzyme catalyzes the conjugation of glutathione to various harmful substrates, thereby facilitating their excretion. Research into GSTA4 has garnered significant attention due to its implications in various disease states, including cancer, neurodegenerative disorders, and inflammation. Dysregulation of GSTA4 expression and activity is often associated with increased susceptibility to toxic agents and the progression of diseases. Moreover, GSTA4 polymorphisms have been linked to individual variations in drug metabolism and therapeutic responses. Recombinant GSTA4 proteins are being extensively studied to elucidate their structural and functional characteristics, enabling the discovery of potential inhibitors or activators that could be used in therapeutic approaches. The recombinant production of GSTA4 allows for detailed biochemical studies and the development of novel strategies to modulate its activity, thereby providing insights into its biological significance and therapeutic potential. By exploring the role of GSTA4 in biological systems through recombinant technology, researchers aim to enhance the understanding of its involvement in pathophysiological processes and to identify novel therapeutic targets for intervention in related diseases. This growing body of research emphasizes the importance of GSTA4 not only in detoxification pathways but also in broader metabolic contexts, underscoring its potential as a biomarker and a target for drug development.